These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7504239)

  • 21. Biochemical and functional interactions between HIV-1 Tat protein and TAR RNA.
    Rana TM; Jeang KT
    Arch Biochem Biophys; 1999 May; 365(2):175-85. PubMed ID: 10328810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RNA-ligand interactions: affinity and specificity of aminoglycoside dimers and acridine conjugates to the HIV-1 Rev response element.
    Luedtke NW; Liu Q; Tor Y
    Biochemistry; 2003 Oct; 42(39):11391-403. PubMed ID: 14516190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A dynamic in vivo view of the HIV-I Rev-RRE interaction.
    Charpentier B; Stutz F; Rosbash M
    J Mol Biol; 1997 Mar; 266(5):950-62. PubMed ID: 9086273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequence requirements for Rev multimerization in vivo.
    Madore SJ; Tiley LS; Malim MH; Cullen BR
    Virology; 1994 Jul; 202(1):186-94. PubMed ID: 7516596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Splicing regulatory elements within tat exon 2 of human immunodeficiency virus type 1 (HIV-1) are characteristic of group M but not group O HIV-1 strains.
    Bilodeau PS; Domsic JK; Stoltzfus CM
    J Virol; 1999 Dec; 73(12):9764-72. PubMed ID: 10559286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional consequences of natural sequence variation in the activation domain of HIV-1 Rev.
    Hua J; Caffrey JJ; Cullen BR
    Virology; 1996 Aug; 222(2):423-9. PubMed ID: 8806526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recognition of the high affinity binding site in rev-response element RNA by the human immunodeficiency virus type-1 rev protein.
    Iwai S; Pritchard C; Mann DA; Karn J; Gait MJ
    Nucleic Acids Res; 1992 Dec; 20(24):6465-72. PubMed ID: 1282702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel mono- and di-DNA-enzymes targeted to cleave TAT or TAT-REV RNA inhibit HIV-1 gene expression.
    Unwalla H; Banerjea AC
    Antiviral Res; 2001 Aug; 51(2):127-39. PubMed ID: 11431037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Regulatory mechanism of HIV gene expression].
    Hatanaka M
    Nihon Rinsho; 1993 Sep; 51 Suppl():43-57. PubMed ID: 8271415
    [No Abstract]   [Full Text] [Related]  

  • 30. The arginine-rich domains present in human immunodeficiency virus type 1 Tat and Rev function as direct importin beta-dependent nuclear localization signals.
    Truant R; Cullen BR
    Mol Cell Biol; 1999 Feb; 19(2):1210-7. PubMed ID: 9891055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein.
    Schwartz S; Felber BK; Pavlakis GN
    J Virol; 1992 Jan; 66(1):150-9. PubMed ID: 1727477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiviral effects of human immunodeficiency virus type 1-specific small interfering RNAs against targets conserved in select neurotropic viral strains.
    Dave RS; Pomerantz RJ
    J Virol; 2004 Dec; 78(24):13687-96. PubMed ID: 15564478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors.
    Amendt BA; Si ZH; Stoltzfus CM
    Mol Cell Biol; 1995 Aug; 15(8):4606-15. PubMed ID: 7623852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The development and testing of retroviral vectors expressing trans-dominant mutants of HIV-1 proteins to confer anti-HIV-1 resistance.
    Liem SE; Ramezani A; Li X; Joshi S
    Hum Gene Ther; 1993 Oct; 4(5):625-34. PubMed ID: 8280800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference.
    Coburn GA; Cullen BR
    J Virol; 2002 Sep; 76(18):9225-31. PubMed ID: 12186906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination gene therapy: synergistic inhibition of human immunodeficiency virus Tat and Rev functions by a single RNA molecule.
    Lisziewicz J; Zeng G; Gratas C; Weinstein JN; Lori F
    Hum Gene Ther; 2000 Apr; 11(6):807-15. PubMed ID: 10779158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV-1 Rev regulation involves recognition of non-Watson-Crick base pairs in viral RNA.
    Bartel DP; Zapp ML; Green MR; Szostak JW
    Cell; 1991 Nov; 67(3):529-36. PubMed ID: 1934059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. B-cell epitopes in HIV-1 Tat and Rev proteins colocalize with T-cell epitopes and with functional domains.
    Tähtinen M; Ranki A; Valle SL; Ovod V; Krohn K
    Biomed Pharmacother; 1997; 51(10):480-7. PubMed ID: 9863510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aminoglycoside antibiotics, neamine and its derivatives as potent inhibitors for the RNA-protein interactions derived from HIV-1 activators.
    Hamasaki K; Ueno A
    Bioorg Med Chem Lett; 2001 Feb; 11(4):591-4. PubMed ID: 11229778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molding a peptide into an RNA site by in vivo peptide evolution.
    Harada K; Martin SS; Tan R; Frankel AD
    Proc Natl Acad Sci U S A; 1997 Oct; 94(22):11887-92. PubMed ID: 9342332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.